Kabra Drugs has informed that a meeting of the Board of Directors of the Company will be held on Wednesday, June 18, 2025 at 5:00 pm in Company's Chennai Office to take on record the following matter: 1. New acquisition 2. New drug license for a Chennai office 3. Diversification by creating new subsidiary 4. Any other agenda with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.